Changzhou Qianhong Biopharma Co (SZSE:002550) EV-to-Revenue : 4.03 (As of May. 09, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Changzhou Qianhong Biopharma Co's enterprise value is ¥6,717 Mil. Changzhou Qianhong Biopharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,667 Mil. Therefore, Changzhou Qianhong Biopharma Co's EV-to-Revenue for today is 4.03.

The historical rank and industry rank for Changzhou Qianhong Biopharma Co's EV-to-Revenue or its related term are showing as below:

SZSE:002550' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.06 Med: 4.62 Max: 27.21
Current: 4.03

During the past 13 years, the highest EV-to-Revenue of Changzhou Qianhong Biopharma Co was 27.21. The lowest was 2.06. And the median was 4.62.

SZSE:002550's EV-to-Revenue is ranked worse than
68.52% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs SZSE:002550: 4.03

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-09), Changzhou Qianhong Biopharma Co's stock price is ¥5.78. Changzhou Qianhong Biopharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.29. Therefore, Changzhou Qianhong Biopharma Co's PS Ratio for today is 4.47.

Changzhou Qianhong Biopharma Co EV-to-Revenue Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co EV-to-Revenue Chart

Changzhou Qianhong Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

3.19

2.83

2.97

3.31

3.83

Changzhou Qianhong Biopharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															3.11	2.88	2.93	3.83	3.38

Competitive Comparison of Changzhou Qianhong Biopharma Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Changzhou Qianhong Biopharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Changzhou Qianhong Biopharma Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changzhou Qianhong Biopharma Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Changzhou Qianhong Biopharma Co's EV-to-Revenue falls into.

Changzhou Qianhong Biopharma Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Changzhou Qianhong Biopharma Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	6716.676	/	1667.151
	=	4.03

Changzhou Qianhong Biopharma Co's current Enterprise Value is ¥6,717 Mil.
Changzhou Qianhong Biopharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,667 Mil.

Changzhou Qianhong Biopharma Co (SZSE:002550) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Changzhou Qianhong Biopharma Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5.78	/	1.293
	=	4.47

Changzhou Qianhong Biopharma Co's share price for today is ¥5.78.
Changzhou Qianhong Biopharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.29.

Changzhou Qianhong Biopharma Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Changzhou Qianhong Biopharma Co (SZSE:002550) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022

Website

http://www.qhsh.com.cn

Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Changzhou Qianhong Biopharma Co (SZSE:002550) Headlines

No Headlines